TYVASO is a Oral Inhalant in the Human Prescription Drug category. It is labeled and distributed by United Therapeutics Corporation. The primary component is Treprostinil.
| Product ID | 66302-206_1cd808bf-a8ed-44bb-b7e3-6872c9afa6c6 |
| NDC | 66302-206 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TYVASO |
| Generic Name | Treprostinil |
| Dosage Form | Inhalant |
| Route of Administration | ORAL |
| Marketing Start Date | 2009-08-14 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022387 |
| Labeler Name | United Therapeutics Corporation |
| Substance Name | TREPROSTINIL |
| Active Ingredient Strength | 2 mg/2.9mL |
| Pharm Classes | Prostacycline Vasodilator [EPC],Prostaglandins I [CS],Vasodilation [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2009-08-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022387 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-08-14 |
| Marketing Category | NDA |
| Application Number | NDA022387 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-08-14 |
| Marketing Category | NDA |
| Application Number | NDA022387 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-08-14 |
| Marketing Category | NDA |
| Application Number | NDA022387 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-08-14 |
| Ingredient | Strength |
|---|---|
| TREPROSTINIL | 1.74 mg/2.9mL |
| SPL SET ID: | cbc31ab1-a80f-4b50-a3b1-39910b0fb609 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 66302-206 | TYVASO | TYVASO |
| 66302-101 | Remodulin | treprostinil |
| 66302-102 | Remodulin | treprostinil |
| 0703-0666 | Treprostinil | Treprostinil |
| 0703-0676 | Treprostinil | Treprostinil |
| 0703-0686 | Treprostinil | Treprostinil |
| 0703-0696 | Treprostinil | Treprostinil |
| 0781-3420 | Treprostinil | treprostinil |
| 0781-3425 | Treprostinil | treprostinil |
| 0781-3427 | Treprostinil | treprostinil |
| 0781-3430 | Treprostinil | treprostinil |
| 42023-206 | Treprostinil | Treprostinil |
| 42023-207 | Treprostinil | Treprostinil |
| 42023-208 | Treprostinil | Treprostinil |
| 42023-209 | Treprostinil | Treprostinil |
| 62332-514 | Treprostinil | Treprostinil |
| 62332-515 | Treprostinil | Treprostinil |
| 62332-516 | Treprostinil | Treprostinil |
| 62332-517 | Treprostinil | Treprostinil |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TYVASO 77425786 3709561 Live/Registered |
UNITED THERAPEUTICS CORPORATION 2008-03-19 |